-
Something wrong with this record ?
Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go
S. Pospisilova, LA. Sutton, J. Malcikova, E. Tausch, D. Rossi, E. Montserrat, C. Moreno, K. Stamatopoulos, G. Gaidano, R. Rosenquist, P. Ghia, . ,
Language English Country Italy
Document type Editorial, Research Support, Non-U.S. Gov't
Grant support
NV15-30015A
MZ0
CEP Register
NV15-31834A
MZ0
CEP Register
Digital library NLK
Full text - Article
Full text - Article
Source
Source
NLK
Directory of Open Access Journals
from 1994
Free Medical Journals
from 1994
Freely Accessible Science Journals
from 1994
PubMed Central
from 2009
Europe PubMed Central
from 2009
Open Access Digital Library
from 1994-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1996
- MeSH
- Alleles MeSH
- Bridged Bicyclo Compounds, Heterocyclic therapeutic use MeSH
- Quinazolinones therapeutic use MeSH
- Leukemia, Lymphocytic, Chronic, B-Cell diagnosis drug therapy genetics pathology MeSH
- Molecular Targeted Therapy MeSH
- Gene Expression MeSH
- Class I Phosphatidylinositol 3-Kinases antagonists & inhibitors genetics metabolism MeSH
- Gene Frequency MeSH
- Humans MeSH
- Biomarkers, Tumor genetics metabolism MeSH
- Tumor Suppressor Protein p53 deficiency genetics MeSH
- Prognosis MeSH
- Antineoplastic Agents therapeutic use MeSH
- Purines therapeutic use MeSH
- Pyrazoles therapeutic use MeSH
- Pyrimidines therapeutic use MeSH
- Sulfonamides therapeutic use MeSH
- Protein-Tyrosine Kinases antagonists & inhibitors genetics metabolism MeSH
- High-Throughput Nucleotide Sequencing MeSH
- Check Tag
- Humans MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- Editorial MeSH
Department of Internal Medicine 3 Ulm University Germany
Hematology Department Hospital de la Santa Creu i Sant Pau Barcelona Spain
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17014065
- 003
- CZ-PrNML
- 005
- 20201105114510.0
- 007
- ta
- 008
- 170413s2016 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3324/haematol.2015.139246 $2 doi
- 035 __
- $a (PubMed)26928246
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Pospisilova, Sarka $u Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 245 10
- $a Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go / $c S. Pospisilova, LA. Sutton, J. Malcikova, E. Tausch, D. Rossi, E. Montserrat, C. Moreno, K. Stamatopoulos, G. Gaidano, R. Rosenquist, P. Ghia, . ,
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a protinádorové látky $x terapeutické užití $7 D000970
- 650 _2
- $a nádorové biomarkery $x genetika $x metabolismus $7 D014408
- 650 _2
- $a bicyklické sloučeniny heterocyklické $x terapeutické užití $7 D019086
- 650 _2
- $a fosfatidylinositol-3-kinasy třídy I $x antagonisté a inhibitory $x genetika $x metabolismus $7 D058534
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a frekvence genu $7 D005787
- 650 _2
- $a vysoce účinné nukleotidové sekvenování $7 D059014
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a chronická lymfatická leukemie $x diagnóza $x farmakoterapie $x genetika $x patologie $7 D015451
- 650 _2
- $a cílená molekulární terapie $7 D058990
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a tyrosinkinasy $x antagonisté a inhibitory $x genetika $x metabolismus $7 D011505
- 650 _2
- $a puriny $x terapeutické užití $7 D011687
- 650 _2
- $a pyrazoly $x terapeutické užití $7 D011720
- 650 _2
- $a pyrimidiny $x terapeutické užití $7 D011743
- 650 _2
- $a chinazolinony $x terapeutické užití $7 D052999
- 650 _2
- $a sulfonamidy $x terapeutické užití $7 D013449
- 650 _2
- $a nádorový supresorový protein p53 $x nedostatek $x genetika $7 D016159
- 655 _2
- $a úvodníky $7 D016421
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Sutton, Lesley-Ann $u Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
- 700 1_
- $a Malcikova, Jitka $u Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Tausch, Eugen $u Department of Internal Medicine III, Ulm University, Germany.
- 700 1_
- $a Rossi, Davide $u Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
- 700 1_
- $a Montserrat, Emili $u Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, University of Barcelona, Spain.
- 700 1_
- $a Moreno, Carol $u Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
- 700 1_
- $a Stamatopoulos, Kostas $u Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
- 700 1_
- $a Gaidano, Gianluca $u Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
- 700 1_
- $a Rosenquist, Richard $u Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
- 700 1_
- $a Ghia, Paolo $u Division of Experimental Oncology and Department of Onco-Hematology, Università Vita-Salute San Raffaele and IRCCS Instituto Scientifico San Raffaele, Milan, Italy ghia.paolo@hsr.it.
- 700 1_
- $a ,
- 773 0_
- $w MED00001963 $t Haematologica $x 1592-8721 $g Roč. 101, č. 3 (2016), s. 263-5
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26928246 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20201105114508 $b ABA008
- 999 __
- $a ok $b bmc $g 1200530 $s 974843
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 101 $c 3 $d 263-5 $i 1592-8721 $m Haematologica $n Haematologica $x MED00001963
- GRA __
- $a NV15-30015A $p MZ0
- GRA __
- $a NV15-31834A $p MZ0
- LZP __
- $a Pubmed-20170413